- Investing Ideas
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
11
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
11 companies
CorMedix
Market Cap: US$650.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.42
7D
0.2%
1Y
-22.5%
Protalix BioTherapeutics
Market Cap: US$186.1m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.38
7D
-2.5%
1Y
64.1%
Rigel Pharmaceuticals
Market Cap: US$771.0m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$40.54
7D
-4.7%
1Y
115.6%
Aurinia Pharmaceuticals
Market Cap: US$2.0b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$15.96
7D
1.1%
1Y
84.9%
Medpace Holdings
Market Cap: US$15.4b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$537.73
7D
-0.09%
1Y
72.4%
ACADIA Pharmaceuticals
Market Cap: US$4.4b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$25.60
7D
-2.4%
1Y
13.5%
TG Therapeutics
Market Cap: US$7.8b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$54.87
7D
-3.9%
1Y
44.7%
Exelixis
Market Cap: US$14.0b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$55.92
7D
-1.0%
1Y
25.7%
Eli Lilly
Market Cap: US$1.0t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,179.11
7D
-0.8%
1Y
52.8%
Earth Science Tech
Market Cap: US$45.8m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.14
7D
-12.8%
1Y
-22.5%
CapForce
Market Cap: US$247.7m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$20.00
7D
25.0%
1Y
325.5%